Home » Topics » Disease categories and therapies » Respiratory

Respiratory
RSS

Icos acquires additional rights to Abbott's LFA-1 compounds

June 27, 2000

F-1322 dropped from development after reaching phase II

June 27, 2000

Eotaxin found to regulate gastrointestinal allergic reactions

June 27, 2000

Additive or synergistic effects of surfactant and PDE4 inhibitor in acute lung injury

June 26, 2000

LM-1507.Na -- a potent and selective Cys-LT1 receptor antagonist with oral activity

June 26, 2000

Inhibitors of multiple leukotrienes in development for asthma at Czech research institute

June 23, 2000

BIIL-284: preclinical profile of a new, orally active LTB4 antagonist

June 23, 2000

Antiallergic agents from JT inhibit the production of IgE and IL-5

June 22, 2000

Three newly issued patents cover novel CCR3 receptor antagonists synthesized at SmithKline Beecham

June 21, 2000

New PDE4/TNF inhibitors with superior physicochemical and pharmacokinetic profile

June 19, 2000

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 12, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 9, 2026
Skape Bio unlocks GPCR targets with de novo-designed miniproteins
BioWorld
Modulating G protein-coupled receptors (GPCRs) is one of the major challenges in biomedicine. These are flexible proteins with small, deep binding pockets. The...
Pre-disease plasma signature may help redefine lung cancer risk
BioWorld
Researchers have identified a 14-protein blood signature that can predict lung cancer risk as much as five years before diagnosis, and the findings could help...
New 5-HT2C receptor agonists reported in Hansoh patent
BioWorld Science
Researchers from Jiangsu Hansoh Pharmaceutical Group Co. Ltd. and Shanghai Hansoh Biomedical Co. Ltd. have disclosed tricyclic compounds acting as 5-HT2C receptor...